Yi-feng Tian - Publications

Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy.

Journal: Molecular cancer

Published: September 09, 2025

TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis.

Journal: Cancer research

Published: December 11, 2024

Escherichia coli-Induced cGLIS3-Mediated Stress Granules Activate the NF-κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 29, 2023

A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 11, 2023

Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma.

Journal: BMC cancer

Published: February 08, 2023

Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 17, 2022

Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of "waiting time": a preliminary report.

Journal: BMC cancer

Published: August 08, 2022

Induced expression of CCL19 promotes the anti-tumor ability of CAR-T cells by increasing their infiltration ability.

Journal: Frontiers in immunology

Published: June 01, 2022

Circular RNA circ-MTHFD1L induces HR repair to promote gemcitabine resistance via the miR-615-3p/RPN6 axis in pancreatic ductal adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 26, 2022

SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.

Journal: Cell reports

Published: November 12, 2021

CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.

Journal: Journal of hematology & oncology

Published: January 10, 2021

Construction and Validation of Novel Nomograms for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma After Surgery According to Different Primary Cancer Locations.

Journal: Frontiers in oncology

Published: December 24, 2020